Leone Patterson
Director of Finance/CFO presso TENAYA THERAPEUTICS, INC.
Patrimonio netto: 532 403 $ in data 31/03/2024
Posizioni attive di Leone Patterson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NKARTA, INC. | Director/Board Member | 27/04/2020 | - |
| Independent Dir/Board Member | 27/04/2020 | - | |
| TENAYA THERAPEUTICS, INC. | Director of Finance/CFO | 01/06/2021 | - |
| OXFORD BIOMEDICA PLC | Director/Board Member | 01/05/2023 | - |
| Independent Dir/Board Member | 01/05/2023 | - |
Storia della carriera di Leone Patterson
Precedenti posizioni note di Leone Patterson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ELIEM THERAPEUTICS, INC. | Director/Board Member | 01/03/2021 | 19/01/2023 |
| Independent Dir/Board Member | 01/03/2021 | 19/01/2023 | |
| ADVERUM BIOTECHNOLOGIES, INC. | Comptroller/Controller/Auditor | 28/01/2021 | 24/06/2021 |
| Director/Board Member | 17/10/2018 | 15/06/2020 | |
| Chief Executive Officer | 03/05/2018 | 15/06/2020 | |
| Director of Finance/CFO | 28/01/2021 | 24/06/2021 | |
| Investor Relations Contact | 13/06/2016 | - | |
| President | 13/12/2019 | 24/06/2021 | |
| DIADEXUS, INC. | Comptroller/Controller/Auditor | 02/03/2015 | - |
| Director of Finance/CFO | 02/03/2015 | 01/06/2016 | |
Transcept Pharma, Inc.
 Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | Director of Finance/CFO | 25/06/2012 | 30/10/2014 |
| NETAPP, INC. | Comptroller/Controller/Auditor | 01/11/2010 | 01/06/2012 |
| EXELIXIS, INC. | Corporate Officer/Principal | 01/07/2007 | 01/11/2010 |
| ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Leone Patterson
| Chapman University | Undergraduate Degree |
| St. Mary's College (Indiana) | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 13 |
| Svizzera | 2 |
| Regno Unito | 2 |
Posizioni
| Director of Finance/CFO | 4 |
| Comptroller/Controller/Auditor | 4 |
| Director/Board Member | 4 |
Settori
| Health Technology | 11 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 8 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| NOVARTIS AG | Health Technology |
| OXFORD BIOMEDICA PLC | Health Technology |
| NETAPP, INC. | Electronic Technology |
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| NKARTA, INC. | Health Technology |
| TENAYA THERAPEUTICS, INC. | Health Technology |
| ELIEM THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | Health Technology |
Diadexus, Inc.
 Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Leone Patterson
- Esperienza
